Inventor · disambiguated record
Jing-Ping Liou
Also filed as: LIOU JING-PING
23 granted patents·8 pending applications·153 citations·filing 2002–2025
93Inventor score
Files withUNIV TAIPEI MEDICAL17CALGENT BIOTECHNOLOGY CO LTD6NAT HEALTH RESEARCH INSTITUTES5CHEN CHING-SHIH1CHEN YI JEN1
Top patents by PatentIndex Score
31 records- 0195US6933316B2Indole compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2002·Granted Aug 23, 2005·53 cites·39 claims
- 0293US7741495B2Indoline-sulfonamides compoundsUNIV TAIPEI MEDICAL·Filed 2007·Granted Jun 22, 2010·29 cites·25 claims
- 0392US7528165B2Indole compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted May 5, 2009·13 cites·18 claims
- 0491US7456289B2Anti-tumor compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Nov 25, 2008·36 cites·29 claims
- 0590US7632955B2Indole compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Dec 15, 2009·10 cites·7 claims
- 0686US11278523B2Indoline derivatives for treatment and/or prevention of fibrosis diseasesUNIV TAIPEI MEDICAL·Filed 2015·Granted Mar 22, 2022·3 cites·12 claims
- 0784US8846748B2Indolyl or indolinyl hydroxamate compoundsCHEN CHING-SHIH·Filed 2011·Granted Sep 30, 2014·5 cites·19 claims
- 0878US2024246915A1Aminonaphthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2024·Application pending·0 cites
- 0975US12453708B2Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2023·Granted Oct 28, 2025·0 cites·9 claims
- 1071US9296692B2Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injuryCHEN YI-JEN·Filed 2012·Granted Mar 29, 2016·3 cites·5 claims
- 1167US11084786B2Compounds and pharmaceutical composition associated with ubiquitination-proteasome systemCALGENT BIOTECHNOLOGY CO LTD·Filed 2020·Granted Aug 10, 2021·0 cites·12 claims
- 1265US2022184032A1Indoline derivatives for treatment and/or prevention of fibrosis diseasesUNIV TAIPEI MEDICAL·Filed 2022·Application pending·0 cites
- 1364US11919858B2Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2020·Granted Mar 5, 2024·0 cites·5 claims
- 1464US2025346563A1Histone deacetylase 6 inhibitors and method for treating neuropathic painUNIV TAIPEI MEDICAL·Filed 2025·Application pending·0 cites
- 1561US8119683B2Aryl substituted sulfonamide compounds and their use as anticancer agentsLIOU JING-PING·Filed 2010·Granted Feb 21, 2012·1 cites·10 claims
- 1660US10577328B2Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseasesUNIV TAIPEI MEDICAL·Filed 2015·Granted Mar 3, 2020·0 cites·11 claims
- 1759US9598364B2Indolyl or indolinyl hydroxamate compoundsUNIV TAIPEI MEDICAL·Filed 2014·Granted Mar 21, 2017·0 cites·16 claims
- 1859US2024398823A1Dual inhibitor of histone deacetylase 6 and heat shock protein 90UNIV TAIPEI MEDICAL·Filed 2022·Application pending·0 cites
- 1956US11903907B2Soluble honokiol derivativesUNIV TAIPEI MEDICAL·Filed 2020·Granted Feb 20, 2024·0 cites·18 claims
- 2055US10745350B2Compounds and pharmaceutical composition associated with ubiquitination-proteasome systemCALGENT BIOTECHNOLOGY CO LTD·Filed 2016·Granted Aug 18, 2020·0 cites·17 claims
- 2154US11427544B2Histone deacetylase 6 inhibitors and use thereofUNIV TAIPEI MEDICAL·Filed 2017·Granted Aug 30, 2022·0 cites·8 claims
- 2253US7560491B2Z-stilbenes derivatives and the pharmaceutical composition thereofUNIV TAIPEI MEDICAL·Filed 2007·Granted Jul 14, 2009·0 cites·24 claims
- 2351US2022251043A1Histone deacetylase 6 inhibitors and method for treating neuropathic painUNIV TAIPEI MEDICAL·Filed 2020·Application pending·0 cites
- 2451US2019117587A1Soluble honokiol derivativesUNIV TAIPEI MEDICAL·Filed 2018·Application pending·0 cites
- 2549US11479528B2Heat shock protein 90 inhibitorsUNIV TAIPEI MEDICAL·Filed 2018·Granted Oct 25, 2022·0 cites·19 claims
- 2647US11833122B2Aminonaphthoquinone compounds for treatment and/or prevention of fibrosis diseasesCALGENT BIOTECHNOLOGY CO LTD·Filed 2016·Granted Dec 5, 2023·0 cites·4 claims
- 2744US10246455B2Histone deacetylase inhibitorsUNIV TAIPEI MEDICAL·Filed 2015·Granted Apr 2, 2019·0 cites·9 claims
- 2842US2015368195A1Indoline compounds for treatment and/or prevention of inflammation diseasesUNIV TAIPEI MEDICAL·Filed 2014·Application pending·0 cites
- 2941US10745433B2Compounds for inhibiting cancer and virusUNIV TAIPEI MEDICAL·Filed 2017·Granted Aug 18, 2020·0 cites·13 claims
- 3041US10624897B2Chlorobenzene substituted azaaryl compoundsUNIV TAIPEI MEDICAL·Filed 2016·Granted Apr 21, 2020·0 cites·17 claims
- 3138US2011275643A1Aroylquinoline compoundsNAT HEALTH RESEARCH INSTITUTES·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing-Ping Liou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →